References
- WangKYinXMChaoDTMillimanCLKorsmeyerSJBID: a novel BH3 domain-only death agonistGenes Dev19961022285928698918887
- YinXMBid, a BH3-only multi-functional molecule, is at the cross road of life and deathGene200636971916446060
- LiHZhuHXuCJYuanJCleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosisCell19989444915019727492
- LuoXBudihardjoIZouHSlaughterCWangXBid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptorsCell19989444814909727491
- KonigHGRehmMGudorfDFull length Bid is sufficient to induce apoptosis of cultured rat hippocampal neuronsBMC Cell Biol2007871417326836
- SarigRZaltsmanYMarcellusRCFlavellRMakTWGrossABID-D59A is a potent inducer of apoptosis in primary embryonic fibroblastsJ Biol Chem200327812107071071512519725
- ValentijnAJGilmoreAPTranslocation of full-length Bid to mitochondria during anoikisJ Biol Chem200427931328483285715148322
- SongGChenGGYunJPLaiPBSAssociation of p53 with Bid induces cell death in response to etoposide treatment in hepatocellular carcinomaCurr Cancer Drug Targets20099787188020025574
- SongGChenGGChauDKMiaoJLaiPBSBid exhibits S phase checkpoint activation and plays a pro-apoptotic role in response to etoposide-induced DNA damage in hepatocellular carcinoma cellsApoptosis200813569370118373075
- ZinkelSSHurovKEOngCAbtahiFMGrossAKorsmeyerSJA role for proapoptotic BID in the DNA-damage responseCell2005122457959116122425
- KamerISarigRZaltsmanYProapoptotic BID is an ATM effector in the DNA-damage responseCell2005122459360316122426
- KaufmannTTaiLEkertPGThe BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrestCell2007129242343317448999
- BaiLNiHMChenXDifrancescaDYinXMDeletion of bid impedes cell proliferation and hepatic carcinogenesisAm J Pathol200516651523153215855651
- SongGOuyangGBaoSThe activation of Akt/PKB signaling pathway and cell survivalJ Cell Mol Med200591597115784165
- KimEKChoiEJPathological roles of MAPK signaling pathways in human diseasesBiochim Biophys Acta20101802439640520079433
- LiuSQYuJPYuHGLvPChenHLActivation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cellsDig Liver Dis200638531031816527552
- Di MaioMDe MaioEPerroneFPignataSDanieleBHepatocellular carcinoma: systemic treatmentsJ Clin Gastroenterol200235Suppl 2S109S11412394214
- MiaoJChenGGChunSYChakECLaiPBBid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinomaInt J Oncol200425365165915289866
- MiaoJChenGGChunSYAdenovirus-mediated tBid overexpression results in therapeutic effects on p53-resistant hepatocellular carcinomaInt J Cancer200611981985199316708390
- SongGMingYMaoYBaoSOuyangGOsteopontin prevents curcumin-induced apoptosis and promotes survival through Akt activation via {alpha}v{beta}3 integrins in human gastric cancer cellsExp Biol Med20082331215371545
- SongGOuyangGMaoYBMingYLBaoSHuTHOsteopontin promotes metastatic growth of gastric cancer by augmenting cell survival and invasion through Akt-mediated HIF-1α up-regulation and MMP9 activationJ Cell Mol Med2009138B1706171819602039
- ChenGGLaiPBChakECXuHLeeKMLauWYImmunohistochemical analysis of pro-apoptotic Bid level in chronic hepatitis, hepatocellular carcinoma and liver metastasesCancer Lett20011721758211595132
- KewMCEpidemiology of hepatocellular carcinomaToxicology2002181–1823538
- El-SeragHBHepatocellular carcinoma: an epidemiologic viewJ Clin Gastroenterol2002355 Suppl 2S72S7812394209
- BaldwinELOsheroffNEtoposide, topoisomerase II and cancerCurr Med Chem Anticancer Agents20055436337216101488
- FaraziPADePinhoRAHepatocellular carcinoma pathogenesis: from genes to environmentNat Rev Cancer20066967468716929323
- ClarkASWestKStreicherSDennisPAConstitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cellsMol Cancer Ther20021970771712479367
- KrausACFerberIBachmannSOIn vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathwaysOncogene200221578683869512483521